Welcome! For Prescribing Information including Boxed Warning click the “Visit Website” button. This account is intended for US Healthcare Providers Only.
Check out our community guidelines at https://e.lilly/cg. See Prescribing Information https://e.lilly/kisunlaPI and Medication Guide at https://e.lilly/kisunlaMG.
To report an adverse event, product complaint, or ask an in-depth medical question, please call our help center at 1-800-LillyRx (1-800-545-5979).
Kisunla™ is a trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates. ©Lilly USA, LLC 2024.
Please view our privacy statement here: https://privacynotice.lilly.com/
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Keywords
- Whitehall.
Kisunla™ (Donanemab-Azbt) Hcp Questions
Kisunla™ (Donanemab-Azbt) Hcp's website is https://www.kisunla.lilly.com/hcp
Kisunla™ (Donanemab-Azbt) Hcp's LinkedIn profile is https://www.linkedin.com/company/kisunlahcp
Kisunla™ (Donanemab-Azbt) Hcp's industry is
Pharmaceutical Manufacturing
Kisunla™ (Donanemab-Azbt) Hcp's top competitors are
Oi Infusion,
Infusion Specialists,
Ameripharma Infusion Center,
Liberty Place, Inc.,
Massachusetts Association Of Nurse Anesthesiology,
Leqembi® (Lecanemab-Irmb) Hcp,
Mounjaro® (Tirzepatide) Hcp,
Omaha Pain Physicians,
Eli Lilly And Company,
Bebe Care Pediatrics.
Kisunla™ (Donanemab-Azbt) Hcp's categories are Pharmaceutical Manufacturing
